Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2015112925286N1Phase 3Completed
Phase 3 trial of melatonin in Nonorganic Sleep Disorder, sponsored by Tehran University of Medical Sciences. Primary endpoint: Night sleep quality. Started May 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2015112925286N1.